CLINICAL_TRIALS
trial_result
· 2015-01-09
Clinical Trial Update: Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant [Phase 2]
Summary
Phase 2 randomized trial evaluating yohimbine for type 2 diabetes patients carrying a specific genetic risk variant; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anders Rosengren, MD PhD | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2015-01-09